| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.09 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |